Aspirin may reduce Alzheimer’s disease risk, study suggests

Fox News Health
Published December 01, 2015
Alzheimer Risk Reduced by Aspirin
New research published in the journal PLOS One suggests that salicylic acid, a byproduct of aspirin, prevents an enzyme GAPDH from entering and killing nerves cells causing Alzheimer’s, Parkinson’s and Huntington’s diseases.

Scientists in this current study also observed that a natural derivative of salicylic acid from the Chinese medical herb licorice and a lab-synthesized derivative bind to GAPDH more effectively than salicylic acid. Thus there are prospects for synthesizing more potent and effective treatments for preventing above neurodegenerative disorders.

According to Dr. Harold Levinson, this intriguing research offers amazing insights into prospects for preventing and treating severely debilitating neurodegenerative disorders.

About Dr. Harold Levinson
Formerly Clinical Associate Professor of Psychiatry at New York University Medical Center, Dr. Harold Levinson is currently Director of the Levinson Medical Center for Learning Disabilities in Long Island, New York. He is a well-known neuropsychiatrist, clinical researcher and author. For more information, call 1(800)334-7323 or

Image courtesy of Mister GC/

Comments are closed.